Ophthalmic Med Tech. Firm Sees 166% Gain in LAL Implants
Source: Streetwise Reports  (5/6/22)
Shares of RxSight Inc. traded 7% higher after the company reported Q1/22 financial results which highlighted a 157% YoY increase in revenue and a 208% increase in unit sales of its Light Delivery Devices (LDDâ„¢s) utilized in cataract surgery procedures to implant its RxSight Light Adjustable Lens® (LAL), which it says is "the world's first and only adjustable intraocular lens (IOL) that is customized after cataract surgery." More >

FDA Expands Use for Transcarotid Stent
Source: Streetwise Reports  (5/2/22)
Silk Road Medical Inc. shares traded 12% higher after the company reported that the U.S. FDA granted expanded authorization for its ENROUTE® transcarotid stent system for use in preventing stroke in patients deemed to be at standard risk for adverse events from carotid endarterectomy. More >

Surgical Device Maker's Shares Rise 7% on Q3 Earnings
Source: Streetwise Reports  (4/7/22)
Shares of AngioDynamics Inc. traded higher after the company reported Q3/22 financial results highlighting a 28.6% YoY increase in net Med Tech sales. More >

Shares Rise 10% After FDA Approval of Implantable Lens
Source: Streetwise Reports  (3/28/22)
STAAR Surgical Co. shares traded higher after the company reported that the U.S. FDA approved its EVO Visian® Implantable Collamer® Lenses to correct myopia (nearsightedness) and myopia with astigmatism. More >

Medical Device Co. Changes Tack to Drive Topline Growth
  (3/9/22)
This medical device company is improving its laser ablation system and working toward U.S. approval for its use in a second application, noted a Ladenburg Thalmann report. More >

Co. to Rebound After Q4/21 Sales Down Due to Virus Surge
  (3/1/22)
The 2022 outlook for a cancer detection and therapy solutions company is positive given its focus on dermatology and implementing new commercial strategies, noted an Oppenheimer report. More >

Dialysis Equip. Co. Posts Record FY21 Sales
Source: Streetwise Reports  (2/17/22)
Shares of a wireless mobile dialysis equipment maker traded 15% higher after the company reported FY/21 financial results highlighting a 105% YoY increase in revenue to $102.6 million. More >

FDA Approves First Tubeless Insulin Delivery Device
Source: Streetwise Reports  (1/28/22)
Shares of Insulet Corp. traded 15% higher after the company reported its Omnipod® 5 automated insulin delivery system has received clearance from the U.S. FDA. The Omnipod® 5 is the first tubeless system to be monitored and controlled remotely using a smartphone. More >

FDA Gives Fast Track Status to Firm for Adrenal Rescue Pen
  (1/24/22)
Now with fast track status and positive Phase 1 study results, Antares Pharma plans to advance its ATRS-1902 product candidate into a second trial in Q2/22, noted a Ladenburg Thalmann report. More >

Medical Device Firm Engages Distributor for Its TransDermal Infusion System
Source: Streetwise Reports  (12/6/21)
Sensus Healthcare's "needle-free treatment presents a clear competitive advantage in the aesthetic dermatology space," an H.C. Wainwright & Co. report noted. More >

Robotic Surgical Systems Co.'s Shares Gain 21% on Q3 Earnings and Forward Revenue Outlook
Source: Streetwise Reports  (11/11/21)
Stereotaxis Inc. shares traded higher after the company reported Q3/21 financial results and confirmed its FY/21 revenue guidance. The company added that it is sufficiently funded and is on pace towards doubling its system revenue in FY/22. More >

Robotic Surgical Device Maker's Shares Maneuver Higher on Q3 Earnings
Source: Streetwise Reports  (11/4/21)
Shares of robotic performance-guided surgery device maker Asensus Surgical Inc. traded 21% higher after the company reported Q3/21 financial results that included a 215% increase in YoY revenue. More >

SmileDirectClub Granted Patent for Mobile Oral Care Bus to Serve Remote Regions in the US & UK
Source: Streetwise Reports  (10/5/21)
SmileDirectClub Inc. shares traded 15% higher after the company reported that the U.S. Patent & Trademark Office has allowed its new patent for the firm's mobile SmileBus concept whereby its SmileShop on wheels is mobilized to expand access to convenient, affordable oral care in remote areas across the U.S. and the U.K. More >

Telemedicine Tech Firm Poised to Generate $11 Million of Revenue
Source: Streetwise Reports  (9/24/21)
Reliq Health Technologies signs contracts with three new clients for its proprietary remote healthcare delivery and care tracking platform, which has particularly significant implications during the era of the COVID-19 pandemic. More >

Medical Device Company's Improved Fundamentals Offer Multiple Expansion Potential
Source: Streetwise Reports  (9/7/21)
ROTH Capital Partners LLC commented in a research report that it is maintaining its "Buy" rating and raising its FY/22 revenue estimates for Dynatronics Corp. to $41 million after the firm pre-announced Q4/21 revenue figures that exceeded prior estimates. More >

Third Implantation of Device Firm's Total Artificial Heart That 'Could Save Many Patients Who May Die'
Source: Streetwise Reports  (8/30/21)
An H.C. Wainwright & Co. report noted that Carmat's Aeson implant "could save many patients who may die, due to [a] shortage of donor hearts, while waiting for a heart transplant." More >

Dermatological Device Company to Acquire Laser System Firm
Source: Streetwise Reports  (8/24/21)
An H.C. Wainwright report noted that "this deal is an opportunity for STRATA Skin Sciences to substantially increase its long-term, recurring revenue base." More >

Diagnostics Firm Readies for Pivotal FDA Study of Device That Detects Bacterial Lung Infections
Source: Streetwise Reports  (8/18/21)
Promising early results and a new line of equity support Avisa Diagnostic’s drive for IDE approval of its rapid-response breath test for pneumonia, TB, CF, and other lung ailments. More >

STAAR Shares Burst Higher after Firm Posts 77% Increase in Q2 Net Sales and Raises FY Outlook
Source: Streetwise Reports  (8/6/21)
Shares of STAAR Surgical Co. traded 20% higher after the company reported Q2/21 financial results highlighting a 93% YoY increase in net sales of its Implantable Collamer® Lenses. More >

Coverage Initiated on Company with a 'Genuine Physiological Heart Replacement Therapy'
Source: Streetwise Reports  (7/21/21)
The investment thesis for the device company Carmat, whose therapy "allows patients to live with almost normal quality of life," is presented in an H.C. Wainwright & Co. report. More >

Biopharma Partners with NIH to Advance Women's Hormone-Free Contraceptive
Source: Streetwise Reports  (7/21/21)
A Roth Capital Partners report calls this a "very cost-effective and strategic move" for Daré Bioscience. More >

Zynex Shares Rise as Firm Notches Significant Q2 Order Growth and Raises EBITDA Outlook
Source: Streetwise Reports  (7/16/21)
Zynex Inc. shares traded 10% higher after the electrotherapy medical device maker reported a 247% YoY growth in orders during Q2/21 and raised the range for its EBITDA estimates in the quarter by $1.2 million. More >

Pulse Bio Shares Beat Higher on Launch of CellFX NPS System in Canada
Source: Streetwise Reports  (7/1/21)
Pulse Biosciences shares traded 27% higher after the company announced it secured a $50 million private placement one day after it reported the first CellFX® procedure using its proprietary Nano-Pulse Stimulation technology had been performed in Canada. More >

Second Sight Shares Shine Brightly After Firm Posts Orion Study Results
Source: Streetwise Reports  (5/12/21)
Second Sight Medical Products Inc. shares traded 25% higher after the company reported the results from a two-year study of its Orion Visual Cortical Prosthesis System. More >

AbbVie's Allergan Aesthetics to Acquire Soliton for $550 Million
Source: Streetwise Reports  (5/10/21)
Soliton Inc. shares traded 25% higher after the company reported it had agreed to be acquired by AbbVie Inc.'s Allergan Aesthetics for $22.60 per share in an all cash transaction. More >